logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 12
  • 1
    Ackerman, Brian Everett
    Born in April 1984
    Individual (1 offspring)
    Officer
    2025-10-09 ~ now
    OF - Director → CIF 0
  • 2
    Benecchi, Christopher
    Executive born in November 1971
    Individual (1 offspring)
    Officer
    2025-01-31 ~ 2025-07-31
    OF - Director → CIF 0
  • 3
    Iguchi, Kimi Ellen
    Business Executive born in August 1962
    Individual (1 offspring)
    Officer
    2017-03-01 ~ 2024-10-29
    OF - Director → CIF 0
  • 4
    Dec, Timothy Carroll
    Born in April 1958
    Individual (1 offspring)
    Officer
    2025-10-09 ~ now
    OF - Director → CIF 0
  • 5
    Flanagan, Michael Patrick
    Vp Accounting At Sage Therapeutics, Inc. born in July 1961
    Individual (1 offspring)
    Officer
    2024-10-25 ~ 2025-01-21
    OF - Director → CIF 0
  • 6
    Marsh, Brandon George
    Corporate Counsel At Sage Therapeutics, Inc. born in March 1990
    Individual (1 offspring)
    Officer
    2024-10-25 ~ 2025-07-31
    OF - Director → CIF 0
  • 7
    Khattar, Jack Antoine
    Born in July 1961
    Individual (2 offsprings)
    Officer
    2025-10-09 ~ now
    OF - Director → CIF 0
  • 8
    Roecklein, Bryan Alfred
    Born in May 1959
    Individual (2 offsprings)
    Officer
    2025-10-09 ~ now
    OF - Director → CIF 0
  • 9
    Cook, Anne Marie
    Business Executive born in October 1961
    Individual (2 offsprings)
    Officer
    2017-03-01 ~ 2024-10-29
    OF - Director → CIF 0
  • 10
    ABOGADO NOMINEES LIMITED
    01688036
    Company Secretarial Department, 280, Bishopsgate, London, United Kingdom
    Active Corporate (114 parents, 1700 offsprings)
    Equity (Company account)
    4 GBP2024-06-30
    Officer
    2017-03-01 ~ now
    OF - Secretary → CIF 0
  • 11
    9715, Key West Avenue, Rockville, Md 20850, United States
    Corporate (2 offsprings)
    Person with significant control
    2025-07-31 ~ now
    PE - Right to appoint or remove directors → CIF 0
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
  • 12
    55 Cambridge Parkway, Cambridge, Ma 02142, United States
    Corporate (1 offspring)
    Person with significant control
    2017-03-01 ~ 2025-07-31
    PE - Right to appoint or remove directors → CIF 0
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
parent relation
Company in focus

SAGE THERAPEUTICS LIMITED

Standard Industrial Classification
21200 - Manufacture Of Pharmaceutical Preparations
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Average Number of Employees
32024-01-01 ~ 2024-12-31
32023-01-01 ~ 2023-12-31
Fixed Assets - Investments
39,596 GBP2024-12-31
39,596 GBP2023-12-31
Debtors
Current
2,202,767 GBP2024-12-31
1,930,353 GBP2023-12-31
Cash at bank and in hand
72,369 GBP2024-12-31
65,603 GBP2023-12-31
Current Assets
2,275,136 GBP2024-12-31
1,995,956 GBP2023-12-31
Creditors
Current, Amounts falling due within one year
-269,802 GBP2023-12-31
Net Current Assets/Liabilities
2,054,835 GBP2024-12-31
1,726,154 GBP2023-12-31
Net Assets/Liabilities
2,094,431 GBP2024-12-31
1,765,750 GBP2023-12-31
Equity
Called up share capital
1 GBP2024-12-31
1 GBP2023-12-31
1 GBP2023-01-01
Retained earnings (accumulated losses)
2,094,430 GBP2024-12-31
1,765,749 GBP2023-12-31
1,485,827 GBP2023-01-01
Equity
2,094,431 GBP2024-12-31
1,765,750 GBP2023-12-31
1,485,828 GBP2023-01-01
Profit/Loss
Retained earnings (accumulated losses)
-1,485 GBP2024-01-01 ~ 2024-12-31
32,035 GBP2023-01-01 ~ 2023-12-31
Profit/Loss
-1,485 GBP2024-01-01 ~ 2024-12-31
32,035 GBP2023-01-01 ~ 2023-12-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
-1,485 GBP2024-01-01 ~ 2024-12-31
32,035 GBP2023-01-01 ~ 2023-12-31
Comprehensive Income/Expense
-1,485 GBP2024-01-01 ~ 2024-12-31
32,035 GBP2023-01-01 ~ 2023-12-31
Amounts Owed by Group Undertakings
Current
2,187,847 GBP2024-12-31
1,888,435 GBP2023-12-31
Other Debtors
Current
2,190 GBP2024-12-31
1,742 GBP2023-12-31
Prepayments/Accrued Income
Current
3,072 GBP2024-12-31
29,435 GBP2023-12-31
Debtors - Deferred Tax Asset
Current
9,658 GBP2024-12-31
10,741 GBP2023-12-31
Trade Creditors/Trade Payables
Current
2,085 GBP2023-12-31
Corporation Tax Payable
Current
52,020 GBP2024-12-31
61,809 GBP2023-12-31
Other Creditors
Current
4,527 GBP2024-12-31
21,826 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
163,754 GBP2024-12-31
184,082 GBP2023-12-31
Creditors
Current
220,301 GBP2024-12-31
269,802 GBP2023-12-31
  • SAGE THERAPEUTICS LIMITED
    Info
    Registered number 10646688
    C/o Company Secretarial Department, 280 Bishopsgate, London EC2M 4AG
    PRIVATE LIMITED COMPANY incorporated on 2017-03-01 (9 years). The company status is Active.
    The last date of confirmation statement was made at 2025-02-25
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 9 February 2026 and licensed under the Open Government Licence v3.0.